A combination therapy lacking many of the debilitating effects of traditional cancer treatment effectively manages mantle cell lymphoma, shrinking the malignancy and inducing remissions in the majority of patients, according to new research from Weill Cornell Medicine.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
